Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Counseling Conditions for Thrice Weekly Buprenorphine in a Primary Care Clinic
NCT00023283Phase 2Completed
- Sponsor
- Yale University
- Start
- Aug 2000
- Primary completion
- Dec 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in opioid use disorder (OUD), sponsored by Yale University. Started Aug 2000; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00023283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023283.